Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis cash
Cash and short-term investments held at the end of each period.
Enovis's cash was $12.56M at Jul 3, 2026. For fiscal 2025 it was $36.39M, down 24.5% from the year before. Over ten years it grew -15.6% a year on average. The highest annual figure on record is $680.25M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.39M | -24.5% |
| FY2024 | Dec 31, 2024 | $48.17M | +33.1% |
| FY2023 | Dec 31, 2023 | $36.19M | +49.0% |
| FY2022 | Dec 31, 2022 | $24.30M | -96.4% |
| FY2021 | Dec 31, 2021 | $680.25M | +600.8% |
| FY2020 | Dec 31, 2020 | $97.07M | -11.5% |
| FY2019 | Dec 31, 2019 | $109.63M | +42.1% |
| FY2018 | Dec 31, 2018 | $77.15M | -81.3% |
| FY2017 | Dec 31, 2017 | $411.63M | +97.1% |
| FY2016 | Dec 31, 2016 | $208.81M | +5.7% |
| FY2015 | Dec 31, 2015 | $197.47M | -35.4% |
| FY2014 | Dec 31, 2014 | $305.45M | -1.9% |
| FY2013 | Dec 31, 2013 | $311.30M | -35.5% |
| FY2012 | Dec 31, 2012 | $482.45M | +542.3% |
| FY2011 | Dec 31, 2011 | $75.11M | +24.1% |
| FY2010 | Dec 31, 2010 | $60.54M | +21.2% |
| FY2009 | Dec 31, 2009 | $49.96M | +73.7% |
| FY2008 | Dec 31, 2008 | $28.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $12.56M | -71.5% |
| Q1 FY2026 | Apr 3, 2026 | $33.13M | -13.9% |
| Q4 FY2025 | Dec 31, 2025 | $36.39M | -24.5% |
| Q3 FY2025 | Oct 3, 2025 | $33.62M | -5.1% |
| Q2 FY2025 | Jul 4, 2025 | $44.07M | +25.9% |
| Q1 FY2025 | Apr 4, 2025 | $38.46M | -42.0% |
| Q4 FY2024 | Dec 31, 2024 | $48.17M | +33.1% |
| Q3 FY2024 | Sep 27, 2024 | $35.43M | +10.3% |
| Q2 FY2024 | Jun 28, 2024 | $35.00M | +7.7% |
| Q1 FY2024 | Mar 29, 2024 | $66.27M | +202.6% |
| Q4 FY2023 | Dec 31, 2023 | $36.19M | +49.0% |
| Q3 FY2023 | Sep 29, 2023 | $32.13M | -41.5% |
| Q2 FY2023 | Jun 30, 2023 | $32.49M | -66.0% |
| Q1 FY2023 | Mar 31, 2023 | $21.90M | -96.7% |
| Q4 FY2022 | Dec 31, 2022 | $24.30M | -96.4% |
| Q3 FY2022 | Sep 30, 2022 | $54.96M | -69.0% |
| Q2 FY2022 | Jul 1, 2022 | $95.61M | +53.4% |
| Q1 FY2022 | Apr 1, 2022 | $661.50M | -13.4% |
| Q4 FY2021 | Dec 31, 2021 | $680.25M | +600.8% |
| Q3 FY2021 | Oct 1, 2021 | $177.48M | +167.2% |
| Q2 FY2021 | Jul 2, 2021 | $62.31M | -6.2% |
| Q1 FY2021 | Apr 2, 2021 | $763.65M | +108.9% |
| Q4 FY2020 | Dec 31, 2020 | $97.07M | -11.5% |
| Q3 FY2020 | Oct 2, 2020 | $66.42M | -47.7% |
| Q2 FY2020 | Jul 3, 2020 | $66.40M | -49.7% |
| Q1 FY2020 | Apr 3, 2020 | $365.60M | +50.8% |
| Q4 FY2019 | Dec 31, 2019 | $109.63M | +42.1% |
| Q3 FY2019 | Sep 27, 2019 | $127.07M | -55.6% |
| Q2 FY2019 | Jun 28, 2019 | $131.93M | -48.8% |
| Q1 FY2019 | Mar 29, 2019 | $242.42M | -39.9% |
| Q4 FY2018 | Dec 31, 2018 | $77.15M | -81.3% |
| Q3 FY2018 | Sep 28, 2018 | $285.90M | +9.8% |
| Q2 FY2018 | Jun 29, 2018 | $257.70M | -5.3% |
| Q1 FY2018 | Mar 31, 2018 | $403.24M | +94.0% |
| Q4 FY2017 | Dec 31, 2017 | $411.63M | +97.1% |
| Q3 FY2017 | Sep 29, 2017 | $260.41M | +35.9% |
| Q2 FY2017 | Jun 30, 2017 | $272.23M | – |
| Q1 FY2017 | Mar 31, 2017 | $207.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $208.81M | – |
| Q3 FY2016 | Sep 30, 2016 | $191.66M | – |
See a number that looks wrong?